|
|
|
40
|
7621Z
|
MICROGYNON-30 30MCG | 150MCG TAB (BSP/COL) ETHI
|
ETHINYL ESTRADIOL|LEVONORGESTREL
|
MICROGYNON-30
|
21'S
|
B
|
4.49
|
4.49
|
TABLET
|
0
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
6812
|
CONTRACEPTIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
7621Z
|
MICROGYNON-30 30MCG|150MCG TAB (BSP) ETH (B)
|
ETHINYL ESTRADIOL|LEVONORGESTREL
|
MICROGYNON-30
|
21'S
|
B
|
4.49
|
4.4852
|
PACK
|
3
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
6812
|
CONTRACEPTIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CONTRACEPTIVES
|
|
|
|
|
42
|
7621Z
|
MICROGYNON-30 30MCG|150MCG TAB (BSP) ETHINYL ESTRADIOL|LEVON
|
ETHINYL ESTRADIOL|LEVONORGESTREL
|
MICROGYNON-30
|
21'S
|
BC
|
3.04
|
3.04
|
PACK
|
3
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
6812
|
CONTRACEPTIVES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CONTRACEPTIVES
|
|
|
|
|
40
|
76712
|
ACTILYSE 50MG INJ (BOE/STO) ALTEPLASE
|
ALTEPLASE
|
ACTILYSE
|
2X50MG
|
BQ
|
4,817.93
|
2,408.97
|
INJECTION
|
0
|
VIAL
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
76712
|
ACTILYSE 50MG INJ (BOE) ALTEPLASE (BQ)
|
ALTEPLASE
|
ACTILYSE
|
2X50MG
|
BQ
|
5307.23
|
2653.6143
|
VIAL
|
0
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THROMBOLYTIC AGENTS
|
|
|
|
|
42
|
76712
|
ACTILYSE 50MG INJ (BOE) ALTEPLASE
|
ALTEPLASE
|
ACTILYSE
|
2X50MG
|
BQ
|
5,307.23
|
2,653.62
|
VIAL
|
0
|
VIAL
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
THROMBOLYTIC AGENTS
|
|
|
|
|
40
|
7691C
|
INTERFERON ALPHA 2B 3MU INJ (RLS/AHI)
|
INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
3MU VIAL
|
C
|
49.72
|
49.72
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
7691C
|
INTERFERON ALPHA 2B 3MU INJ (RLS)
|
INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
3MU VIAL
|
C
|
23.65
|
23.6494
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
42
|
7691D
|
RELIFERON 300MU/0.5ML INJ (RLS) INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
RELIFERON
|
3MU VIAL
|
BQ
|
24.14
|
24.14
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2026-04-01
|
2028-03-31
|
|
SC
|
0
|
INTERFERONS
|
|
|
|
|
41
|
77013
|
GOTABIOTIC F 0.1%|0.3% EYE DR (LPO) DEXAMETHASONE|TOBRAMYCIN (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
5ML
|
C
|
7.58
|
7.5841
|
BOTT
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
7701D
|
DEXAMETHASONE/TOBRAMYCIN EYE DR (CIR/AHI)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.16
|
5.16
|
EYE DROP
|
0
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
7701D
|
DEXAMETHASONE|TOBRAMYCIN 0.1%|0.3% EYE DR (CIR) (BQ)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.16
|
5.1648
|
BOTT
|
0
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
7701E
|
DEXAMETHASONE/TOBRAMYCIN EYE DR (KWA/ATB)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.41
|
5.41
|
EYE DROP
|
0
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
7701H
|
TOBRADEX 0.1% | 0.3% EYE DR (NVS/COL) DEXAMETHA
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
21.09
|
21.09
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
7701H
|
TOBRADEX 0.1%|0.3% EYE DR (NVS) DEXAMETHASONE|TOBRAMYCIN (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
23.79
|
23.7853
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
7701H
|
TOBRADEX 0.1%|0.3% EYE DR (NVS) DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
23.79
|
23.79
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
7701J
|
TOBAGRAM D 0.1%|0.3% EYE DR (HAN) DEXAMETHASONE|TOBRAMYCIN (BQ)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
10ML
|
BQ
|
4.27
|
4.2678
|
BOTT
|
0
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
7701J
|
TOBAGRAM D 0.1%|0.3% EYE DR (HAN) DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
10ML
|
BQ
|
4.30
|
4.29
|
BOTT
|
0
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
77022
|
GOTABIOTIC F EYE OINT (LPO/COL) DEXAMETHASON
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
3.5G
|
C
|
11.69
|
11.69
|
EYE OINTMENT
|
0
|
TUBE
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
77022
|
GOTABIOTIC F EYE OINT (LPO) DEXAMETHASO (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
3.5G
|
C
|
12.86
|
12.8577
|
TUBE
|
0
|
BOX
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
